
Brenda Libby Coleman
Examiner (ID: 16325, Phone: (571)272-0665 , Office: P/1624 )
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 2611, 1624, 1611 |
| Total Applications | 3154 |
| Issued Applications | 1970 |
| Pending Applications | 485 |
| Abandoned Applications | 741 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5788633
[patent_doc_number] => 20020160999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-31
[patent_title] => 'Substituted indolines'
[patent_app_type] => new
[patent_app_number] => 10/033241
[patent_app_country] => US
[patent_app_date] => 2001-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14740
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0160/20020160999.pdf
[firstpage_image] =>[orig_patent_app_number] => 10033241
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/033241 | Substituted indolines | Dec 27, 2001 | Abandoned |
Array
(
[id] => 6568661
[patent_doc_number] => 20020165225
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-07
[patent_title] => 'Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof'
[patent_app_type] => new
[patent_app_number] => 10/026949
[patent_app_country] => US
[patent_app_date] => 2001-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5980
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0165/20020165225.pdf
[firstpage_image] =>[orig_patent_app_number] => 10026949
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/026949 | Pharmaceutical compositions containing new polymorphic forms of olanzapine and uses thereof | Dec 26, 2001 | Issued |
Array
(
[id] => 7355300
[patent_doc_number] => 20040048851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-11
[patent_title] => 'Amidinophenylalanine derivatives as thrombin inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/433358
[patent_app_country] => US
[patent_app_date] => 2003-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8274
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20040048851.pdf
[firstpage_image] =>[orig_patent_app_number] => 10433358
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/433358 | Amidinophenylalanine derivatives as thrombin inhibitors | Dec 19, 2001 | Issued |
Array
(
[id] => 5908150
[patent_doc_number] => 20020143008
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-03
[patent_title] => 'CRF receptor antagonists and methods relating thereto'
[patent_app_type] => new
[patent_app_number] => 10/027789
[patent_app_country] => US
[patent_app_date] => 2001-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9043
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0143/20020143008.pdf
[firstpage_image] =>[orig_patent_app_number] => 10027789
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/027789 | CRF receptor antagonists and methods relating thereto | Dec 19, 2001 | Issued |
Array
(
[id] => 7270394
[patent_doc_number] => 20040058912
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 10/450420
[patent_app_country] => US
[patent_app_date] => 2003-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18064
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058912.pdf
[firstpage_image] =>[orig_patent_app_number] => 10450420
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/450420 | Benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists | Dec 18, 2001 | Issued |
Array
(
[id] => 7367795
[patent_doc_number] => 20040092510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-05-13
[patent_title] => 'Novel 2, 3 - benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient'
[patent_app_type] => new
[patent_app_number] => 10/450898
[patent_app_country] => US
[patent_app_date] => 2003-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7185
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0092/20040092510.pdf
[firstpage_image] =>[orig_patent_app_number] => 10450898
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/450898 | 2, 3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient | Dec 18, 2001 | Issued |
Array
(
[id] => 6639241
[patent_doc_number] => 20020086993
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'Crystal modification'
[patent_app_type] => new
[patent_app_number] => 10/024934
[patent_app_country] => US
[patent_app_date] => 2001-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 1461
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086993.pdf
[firstpage_image] =>[orig_patent_app_number] => 10024934
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/024934 | Olanzapine crystal modification | Dec 18, 2001 | Issued |
Array
(
[id] => 917659
[patent_doc_number] => RE040033
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2008-01-22
[patent_title] => 'Process for preparing 2-methyl-thieno-benzodiazepine'
[patent_app_type] => reissue
[patent_app_number] => 10/023132
[patent_app_country] => US
[patent_app_date] => 2001-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7550
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/RE/040/RE040033.pdf
[firstpage_image] =>[orig_patent_app_number] => 10023132
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/023132 | Process for preparing 2-methyl-thieno-benzodiazepine | Dec 17, 2001 | Issued |
Array
(
[id] => 516128
[patent_doc_number] => 07192945
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2007-03-20
[patent_title] => 'Benzothiazepine derivatives'
[patent_app_type] => utility
[patent_app_number] => 10/451262
[patent_app_country] => US
[patent_app_date] => 2001-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50244
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/192/07192945.pdf
[firstpage_image] =>[orig_patent_app_number] => 10451262
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/451262 | Benzothiazepine derivatives | Dec 16, 2001 | Issued |
| 10/018579 | 1,4-diazacycloheptane derivatives as neuroprotective agents | Dec 16, 2001 | Abandoned |
Array
(
[id] => 1014807
[patent_doc_number] => 06894151
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-17
[patent_title] => 'Lithium complexes of N-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, their production and use'
[patent_app_type] => utility
[patent_app_number] => 10/013840
[patent_app_country] => US
[patent_app_date] => 2001-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1931
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/894/06894151.pdf
[firstpage_image] =>[orig_patent_app_number] => 10013840
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/013840 | Lithium complexes of N-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, their production and use | Dec 12, 2001 | Issued |
Array
(
[id] => 6684205
[patent_doc_number] => 20030120069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-26
[patent_title] => 'Pyrrolobenzodiazepines'
[patent_app_type] => new
[patent_app_number] => 10/021213
[patent_app_country] => US
[patent_app_date] => 2001-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 84938
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20030120069.pdf
[firstpage_image] =>[orig_patent_app_number] => 10021213
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/021213 | Pyrrolobenzodiazepines | Dec 11, 2001 | Issued |
Array
(
[id] => 1342703
[patent_doc_number] => 06586422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2003-07-01
[patent_title] => 'Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno d azepine'
[patent_app_type] => B2
[patent_app_number] => 10/020680
[patent_app_country] => US
[patent_app_date] => 2001-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8266
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 125
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/586/06586422.pdf
[firstpage_image] =>[orig_patent_app_number] => 10020680
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/020680 | Pyrazine and triazine derivatives of 1,2,4,5-tetrahydro-Benzo or Thieno d azepine | Dec 11, 2001 | Issued |
Array
(
[id] => 6291642
[patent_doc_number] => 20020055499
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-09
[patent_title] => 'Integrin receptor antagonists'
[patent_app_type] => new
[patent_app_number] => 10/020012
[patent_app_country] => US
[patent_app_date] => 2001-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11756
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20020055499.pdf
[firstpage_image] =>[orig_patent_app_number] => 10020012
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/020012 | Integrin receptor antagonists | Dec 11, 2001 | Abandoned |
Array
(
[id] => 1089411
[patent_doc_number] => 06828327
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-12-07
[patent_title] => 'Macroheterocylic compounds useful as kinase inhibitors'
[patent_app_type] => B2
[patent_app_number] => 10/008982
[patent_app_country] => US
[patent_app_date] => 2001-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33426
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/828/06828327.pdf
[firstpage_image] =>[orig_patent_app_number] => 10008982
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/008982 | Macroheterocylic compounds useful as kinase inhibitors | Dec 5, 2001 | Issued |
Array
(
[id] => 711090
[patent_doc_number] => 07056910
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-06-06
[patent_title] => '1,4,5.6-tetrahydroimidazo[4,5-d]diazepine derivatives or salts thereof'
[patent_app_type] => utility
[patent_app_number] => 10/432732
[patent_app_country] => US
[patent_app_date] => 2001-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9458
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/056/07056910.pdf
[firstpage_image] =>[orig_patent_app_number] => 10432732
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/432732 | 1,4,5.6-tetrahydroimidazo[4,5-d]diazepine derivatives or salts thereof | Nov 26, 2001 | Issued |
Array
(
[id] => 6622430
[patent_doc_number] => 20020065258
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-30
[patent_title] => 'Non-estrogenic estradiol derivative compounds with antioxidative activity'
[patent_app_type] => new
[patent_app_number] => 09/990517
[patent_app_country] => US
[patent_app_date] => 2001-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4129
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20020065258.pdf
[firstpage_image] =>[orig_patent_app_number] => 09990517
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/990517 | Non-estrogenic estradiol derivative compounds with antioxidative activity | Nov 20, 2001 | Abandoned |
| 09/926031 | Dopamine d1 receptor agonist compounds | Nov 19, 2001 | Abandoned |
Array
(
[id] => 6939803
[patent_doc_number] => 20050113366
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-05-26
[patent_title] => 'Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses'
[patent_app_type] => utility
[patent_app_number] => 10/432692
[patent_app_country] => US
[patent_app_date] => 2001-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 13886
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20050113366.pdf
[firstpage_image] =>[orig_patent_app_number] => 10432692
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/432692 | Derivatives of 4-hydroxybutanoic acid and of its higher homologue as ligands of $g(g)-hydroxybutyrate (ghb) receptors, pharmaceutical compositions containing same and pharmaceutical uses | Nov 15, 2001 | Abandoned |
Array
(
[id] => 7270441
[patent_doc_number] => 20040058959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2004-03-25
[patent_title] => 'Substituted carboxamides'
[patent_app_type] => new
[patent_app_number] => 10/415756
[patent_app_country] => US
[patent_app_date] => 2003-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21178
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0058/20040058959.pdf
[firstpage_image] =>[orig_patent_app_number] => 10415756
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/415756 | Substituted carboxamides | Nov 13, 2001 | Issued |